ConductScience.org, home

Paper · 10433902

Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development.

Lin X and 3 others. Development, 1999. Cited by 298 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Papers, record 10433902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10433902

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development.
PubMed
Journal
Development
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
298
iCite
Relative citation ratio, by iCite
5.55
iCite
Revised in PubMed
2022-02-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin XX
2Buff EME M
3Perrimon NN
4Michelson AMA M

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DrosophilaMajor topic
Drosophila ProteinsMajor topic
Fibroblast Growth FactorsMajor topic
Heparan Sulfate ProteoglycansMajor topic
Protein-Tyrosine KinasesMajor topic
Receptors, Fibroblast Growth FactorMajor topic
Amidohydrolases
Animals
Gene Expression
Genes, Insect
Insect Proteins
Mesoderm
Mitogen-Activated Protein Kinases
Mutation
Phenotype
Signal Transduction
Sulfotransferases
Trachea

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 298 citations.

PMIDTitleJournalYearIn PapersSource
39,729,990Heparan sulfate regulates the fate decisions of human pluripotent stem cells.Stem Cell Reports2025https://conductscience.org/library/papers/39729990PubMed
37,750,089FGFR families: biological functions and therapeutic interventions in tumors.MedComm (2020)2023https://conductscience.org/library/papers/37750089PubMed
37,016,295The genetic basis of wing spots in Pieris canidia butterflies.BMC Genomics2023https://conductscience.org/library/papers/37016295PubMed
36,699,460Regulation of autophagy, lipid metabolism, and neurodegenerative pathology by heparan sulfate proteoglycans.Front Genet2022https://conductscience.org/library/papers/36699460PubMed
36,503,154Neuronal expression of ndst3 in early zebrafish development is responsive to Wnt signaling manipulation.Gene Expr Patterns2023https://conductscience.org/library/papers/36503154PubMed
35,648,312Therapeutic Potential of Skin Stem Cells and Cells of Skin Origin: Effects of Botanical Drugs Derived from Traditional Medicine.Stem Cell Rev Rep2022https://conductscience.org/library/papers/35648312PubMed
35,319,900Coreceptor functions of cell surface heparan sulfate proteoglycans.Am J Physiol Cell Physiol2022https://conductscience.org/library/papers/35319900PubMed
34,124,035In vivo Functional Genomics for Undiagnosed Patients: The Impact of Small GTPases Signaling Dysregulation at Pan-Embryo Developmental Scale.Front Cell Dev Biol2021https://conductscience.org/library/papers/34124035PubMed
32,664,575Cerebellar Morphology and Behavioral Profiles in Mice Lacking Heparan Sulfate Ndst Gene Function.J Dev Biol2020https://conductscience.org/library/papers/32664575PubMed
32,001,716Loss-of-function mutations in UDP-Glucose 6-Dehydrogenase cause recessive developmental epileptic encephalopathy.Nat Commun2020https://conductscience.org/library/papers/32001716PubMed

1 to 10 of 104

See all 104 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10433902

GET https://conductscience.org/api/papers/v1/10433902/cited_by?page=2